Last reviewed · How we verify
NCT06679491: MENSES
Impact of Menstrual Cycle-Based Resistance Training on Neuromuscular Performance in Female Athletes
NA trial testing Resistance periodized training program (N-PF) in Menstrual Cycle in 60 participants. Currently enrolling.
1 July 2025
Quick facts
| Lead sponsor | Universite de La Reunion |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 60 |
| Start date | 1 November 2024 |
| Primary completion | 1 July 2025 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across Reunion |
Drugs / interventions tested
- Resistance periodized training program (N-PF)
- Resistance peioridized training program (N-PL)
- Continuous resistance training program (C)
Conditions studied
- Menstrual Cycle — all drugs for Menstrual Cycle →
- Resistance Training — all drugs for Resistance Training →
- Neuromuscular Function — all drugs for Neuromuscular Function →
- Female Athlete — all drugs for Female Athlete →
Sponsor
Universite de La Reunion
Who can join
18 and older, female only, with Menstrual Cycle or Resistance Training. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to assess the impact of menstrual cycle-based resistance training on neuromuscular function in female athletes. The primary questions it aims to answer are : * Does varying resistance training intensity according to menstrual phases improve maximal knee extensor strength? * How do different training protocols affect voluntary activation, rate of force development, muscle stiffness, and vertical jump height? Researchers will compare natural menstrual cycle groups with an oral contraceptive control group to determine if menstrual phase-specific training influences neuromuscular adaptations. Participants will: * Undergo 2 weekly resistance training sessions over 13 weeks with intensity adjustments based on menstrual phase * Complete periodic neuromuscular assessments across three menstrual phases: early follicular, late follicular, and mid-luteal before and after resistance training intervention
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06679491
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Menstrual Cycle
Currently open trials in the same condition.
- NCT07248046 — Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study) · recruiting
- NCT07242209 — Sugammadex and Menstrual Cycle in Postoperative Nausea and Vomiting · recruiting
- NCT06771583 — Identification and Validation of Epigenetic Biomarkers of PMDD · recruiting
- NCT07258576 — Menstrual Cycle vs. Oral Contraceptives: Effects on Muscle Protein Metabolism After Resistance Exercise · NA · recruiting
- NCT06892080 — Urine Incontinence Occurrence and Sexual Hormones in Women With Chronic Spinal Cord Injury/Disease - a Pilot Study · recruiting
Other Universite de La Reunion trials
Trials by the same sponsor.
- NCT05090241 — Frailty Prevention in Elders From Reunion Island · completed
- NCT06077084 — Neck Strengthening in Non-Specific Chronic Neck Pain · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06679491 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universite de La Reunion
- Last refreshed: 7 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06679491.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing